Lisa A. Kottschade

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0001-8922-2619

发表论文 246 篇 · 总被引 6578 次 · h-index 39

代表论文

Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer (2026 · New England Journal of Medicine · 被引 12)
Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis (2025 · Cancer Immunology Immunotherapy · 被引 11)
Outcomes in Patients With Immune Checkpoint Inhibitor–Related Myopathy and Prolonged Follow-Up (2025 · Neurology Neuroimmunology & Neuroinflammation · 被引 6)
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma (2025 · European Journal of Cancer · 被引 5)
Urinary CXCL-9 outperforms TNF-α for non-invasive diagnosis of immune checkpoint inhibitor–associated acute interstitial nephritis (2026 · Nephrology Dialysis Transplantation · 被引 3)
Case Report: Complete pathologic response in advanced melanoma with SFRT and dual checkpoint inhibition (2025 · Frontiers in Oncology · 被引 3)